← Back to Clinical Trials
Recruiting Phase 3 NCT05939687

NCT05939687 Prophylactic Mesh Placement During Stoma Closure After Low Anterior Resection

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT05939687
Status Recruiting
Phase Phase 3
Sponsor Blokhin's Russian Cancer Research Center
Condition Neoplasms Malignant
Study Type INTERVENTIONAL
Enrollment 142 participants
Start Date 2023-06-05
Primary Completion 2028-12-01

Trial Parameters

Condition Neoplasms Malignant
Sponsor Blokhin's Russian Cancer Research Center
Study Type INTERVENTIONAL
Phase Phase 3
Enrollment 142
Sex ALL
Min Age 18 Years
Max Age 85 Years
Start Date 2023-06-05
Completion 2028-12-01
Interventions
meshnon-mesh

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

The goal of this clinical trial is to compare the efficacy of using polypropylene mesh for hernia prevention after stoma closure in patients with colorectal cancer and non-mesh repair. The main question it aims to answer is: can mesh help prevent hernia? Participants will be divided into 2 groups: with and without mesh using. They must be followed up for 2 years after enrollment in the study. Researchers will compare mesh and non-mesh groups to evaluate the benefits and harms of mesh using in hernia prevention.

Eligibility Criteria

Inclusion Criteria: * Signed informed consent * Absence of distant metastases (M0) * ECOG (Eastern Cooperative Oncology Group) status 0-2 * completed course of adjuvant treatment * Absence of acute inflammatory parastomal complications * Integrity of colorectal anastomosis Exclusion Criteria: * Inability to obtain consent to participate * Synchronous and metachronous malignant neoplasms * Clinically significant diseases of the cardiovascular system, liver, kidney, central nervous system * Parastomal inflammation and other conditions that increase the risk of postoperative complications * Pregnancy * HIV infection

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology